Speakers Platform

Neil Rackham

TOPICS:
Sales
Business
Marketing
Customer Service


FEE CATEGORY:*
20.0k to 25.0k

TRAVELS FROM:
District of Columbia


    Neil Rackham: Profile

    Neil Rackham is known throughout the corporate world as a speaker, writer and seminal thinker on sales and marketing issues. Rackham first gained international recognition in the 1970s when he led the largest-ever research study of successful selling and sales effectiveness. This massive project, supported by major multinationals including Xerox and IBM, involved a team of 30 researchers who studied 35,000 sales calls in over 20 countries. The research took 12 years at a cost, in today’s dollars, of $30 million. From the results of these studies he published the groundbreaking classics SPIN® Selling and Major Account Sales Strategy. More than half the Fortune 500 train their salespeople using sales models derived from his research.

    Widely recognized as a highly creative trainer, Neil Rackham has worked closely with many leading sales forces such as those at IBM, Xerox, AT&T and Citicorp. In addition, he has worked extensively with senior partners in some of the world’s most successful professional services organizations, including McKinsey & Company, where he was for many years a member of the Sales and Channel Management Group.

    Neil Rackham is also a highly sought-after conference speaker who uses a combination of humor, passion and group interaction to stimulate and challenge his audiences. He receives top reviews from audience members for his capacity to take complex issues and make them accessible and interesting.


    * Please note that while this speaker's specific fee falls within the range posted at the top of this page (for Continental U.S. based events), fees are subject to change without notice. Also note that most celebrity keynotes begin in the $25,000 and up range (most list "Contact for Fee Schedule"). For current fee information or international event fees, please contact your Speakers Platform representative.